Loading...
•
Oct 31, 2024
Nordson Q4 2024 Earnings Report
Nordson's Q4 2024 sales increased by 4% and adjusted earnings per share were $2.78.
Key Takeaways
Nordson Corporation reported a 4% increase in sales to $744 million for the fiscal fourth quarter ended October 31, 2024. Adjusted earnings per diluted share were $2.78, and the Atrion Medical acquisition integration is progressing well.
Sales were $744 million, a 4% increase over the prior year.
Earnings per diluted share were $2.12.
Adjusted earnings per diluted share were $2.78.
Atrion Medical acquisition integration is progressing well.
Nordson
Nordson
Nordson Revenue by Segment
Nordson Revenue by Geographic Location
Revenue by Segment
Industrial Precision Revenue
CapyFin.comMedical & Fluid Revenue
CapyFin.comAdvanced Tech Revenue
CapyFin.comRevenue by Geographic Location
Americas Revenue
CapyFin.comEurope Revenue
CapyFin.comAsia Pacific Revenue
CapyFin.com Forward Guidance
Fiscal 2025 forecasted sales range between $2,750 to $2,870 million and adjusted earnings in the range of $9.70 to $10.50
Positive Outlook
- Anticipate delivering sales in the range of $2,750 to $2,870 million in fiscal 2025.
- Full year fiscal 2025 adjusted earnings are forecasted in the range of $9.70 to $10.50 per diluted share.
- First quarter fiscal 2025 sales are forecasted in the range of $615 to $655 million
- First quarter fiscal 2025 adjusted earnings in the range of $1.95 to $2.15 per diluted share.
- Approximately $580 million in backlog.
Challenges Ahead
- Entering 2025 with a conservative viewpoint.
- Fiscal first quarter is seasonally Nordson’s weakest quarter due to the holiday and calendar year-end slowdowns and cautious customer spending.
- Being prudent about expectations for end market recovery timing, particularly for electronics and agricultural product lines.
- Evolving global macro-environment
- Uncertain times
Revenue & Expenses
Visualization of income flow from segment revenue to net income